MIAMI LAKES, FL -- (Marketwired) -- 11/08/13 -- Fuse Science, Inc. (OTCQB: DROP) (www.fusescience.com) announced today that MusclePharm Corporation has become a strategic investor in the Company.

Fuse Science® is a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.

MusclePharm® is a leading sports nutrition company offering vitamins and nutritional supplements which are available in more than 110 countries and in 15,000+ U.S. retail outlets.

Fuse issued and sold 10% senior secured convertible notes in the total amount of $700,000 and warrants to purchase 23,332,00 shares in this financing, with proceeds to be used for specific corporate purposes intended to advance continuing execution of the Fuse business model. In addition to MusclePharm, several other prominent investors participated in the financing. Complete details on the transaction can be found in the Company's 8-K filing with the SEC at www.sec.gov.

"As a Company, we continue to work aggressive strategies to drive expanded distribution and trials of our products, as well as new strategic applications for our technology," said Brian Tuffin, Fuse's Chief Executive Officer. "Our rate of expansion is a function of capital and ground resources to drive broader execution. We believe these strategic investments set the stage for comprehensive progress against both these objectives on a go forward basis."

"The investment in Fuse emanates from our interest in its delivery technology and products," stated Brad Pyatt, Founder and CEO of MusclePharm. "It is aligned with our strategy of leveraging our marketing and distribution channels while bringing both innovation and sophistication to the sport nutrition market. We look forward to continuing ongoing discussions with the Fuse management team and exploring various possibilities for a mutually advantageous strategic relationship."

About MusclePharm Corporation
MusclePharm® is a leading international, award-winning sports nutrition company offering vitamins and nutritional supplements which are available in more than 110 countries and available in 15,000+ U.S. retail outlets, including Costco, Dick's Sporting Goods, 24 Hour Fitness, Bally's, GNC, Vitamin Shoppe and Vitamin World. The company's brands are MusclePharm®, Arnold Schwarzenegger Series™, and FitMiss™. The comprehensive lines of clinically-proven, safe and effective nutritional supplements are developed through a six-stage research process that utilizes the expertise of leading nutritional scientists, doctors and universities. For more information, visit www.musclepharmcorp.com. Follow the company at http://www.facebook.com/MusclePharm and www.Twitter.com/MusclePharm.

About Fuse Science, Inc.
Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products and delivery technology company based in Miami Lakes, Florida. Fuse Science® holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals. The Company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly -- all in a concentrated "DROP" form that is simply applied under the tongue. The Fuse Science® technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products. Information about Fuse Science® is available online at www.fusescience.com and www.poweredbyfuse.com or by calling 305-503-FUSE (3873).

For Fuse Science® news as it happens, follow @FuseScience on Twitter and Like "Fuse Science" on Facebook, www.facebook.com/FuseScience.

Get all Fuse Science® corporate updates sent directly to you; sign up for Fuse News Alerts in the Investor Relations section at www.fusescience.com.

For more information:
Fuse Science, Inc.
Investor Relations
Direct: (305) 503-3873, Ext. 2
Email: [email protected]

Source: Fuse Science, Inc.